E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer
Drug Resistance Updates · 2024-11 · 77 · 101154
DOI: 10.1016/j.drup.2024.101154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-11. Verfasst von Zhuang Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research C…. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Non-small cell lung cancer (NSCLC) remains the foremost contributor to cancer-related fatalities globally, with limited effective therapeutic modalities. Recent research has shed light on the role of ferroptosis in various types of cancers, offering a potential avenue for improving cancer therapy. Herein, we identified E3 ubiquitin ligase deltex 2 (DTX2) as a potential therapeutic target candidate implicated in promoting NSCLC cell growth by inhibiting ferroptosis. Our investigation revealed a significant upregulation of DTX2 in NSCLC cells and tissues, which was correlated with poor prognosis. Downregulation of DTX2 suppressed NSCLC cell growth both in vitro and in vivo, while its overexpression accelerated cell proliferation. Moreover, knockdown of DTX2 promoted ferroptosis in NSCLC cells, which was mitigated by DTX2 overexpression. Mechanistically, we uncovered that DTX2 binds to nuclear receptor coactivator 4 (NCOA4), facilitating its ubiquitination and degradation via the K48 chain, which subsequently dampens NCOA4-driven ferritinophagy and ferroptosis in NSCLC cells. Notably, DTX2 knockdown promotes cisplatin-induced ferroptosis and overcomes drug resistance of NSCLC cells. These findings underscore the critical role of DTX2 in regulating ferroptosis and NCOA4-mediated ferritinophagy, suggesting its potential as a novel therapeutic target for NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer; Tianjin's Clinical Research Center for Cancer; Key L…
- School of Medical Technology, Tianjin Medical University, Tianjin 300203, China.
- Department of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin 300071, China.
- Department of Gastroenterology, Shengli Oilfield Central Hospital 257000, China.
- Department of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin 300071, China; Tianjin Key Laboratory of General Surgery in Construction, Tianjin Union Medical Center, Tianjin 300000, China; Departm…
- School of Medical Technology, Tianjin Medical University, Tianjin 300203, China. Electronic address: shenyanna@tmu.edu.cn.
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Liu, Z., Liu, C., Fan, C., Li, R., Zhang, S., Liu, J., Li, B., Zhang, S., Guo, L., Wang, X., Qi, Z., & Shen, Y. (2024). E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer. Drug Resistance Updates, 77, 101154. https://doi.org/10.1016/j.drup.2024.101154
Vancouver
Liu Z, Liu C, Fan C, Li R, Zhang S, Liu J, et al. E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer. Drug Resistance Updates. 2024;77:101154. doi:10.1016/j.drup.2024.101154
BibTeX
@article{Liu2024,
author = {Liu, Zhuang and Liu, Chang and Fan, Caihong and Li, Runze and Zhang, Shiqi and Liu, Jia and Li, Bo and Zhang, Shengzheng and Guo, Lihong and Wang, Xudong and Qi, Zhi and Shen, Yanna},
title = {E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer},
journal = {Drug Resistance Updates},
year = {2024},
volume = {77},
pages = {101154},
doi = {10.1016/j.drup.2024.101154}
}
EUVIMED